Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
HFA 23: IRONMAN: Anemia, Iron Deficiency and Quality of Life

Paul Kalra

Watch time: 5m 25s
HFA 23: Diagnosis in Heart Failure in Women

John GF Cleland

Watch time: 8m 22s
HFA 23: TRANSFORM-HF: Torsemide Vs Furosemide on Quality of Life in Heart Failure

Stephen J Greene

Watch time: 5m 11s
HFA 23: IRONMAN: Reasons for Hospitalisation and Biomarkers

John GF Cleland

Watch time: 8m 44s
HFA 23: Dapagliflozin and PAD in HF

Jawad Haider Butt

Watch time: 3m 50s
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Harriette Van Spall, James L Januzzi

Watch time: 13m 32s
HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal

Watch time: 8m 47s
HFA 23: MONITOR-HF: Improving QoL& Reducing HF Hospitalisations with PAP Monitoring

Jasper J Brugts

Watch time: 2m 45s

Jasper J Brugts, Ahmad Masri, Marianna Fontana, et al

Watch time: 1h 42m 27s (14 videos)
HFA 23: DAPA-HF and DELIVER: KCCQ in Pts with Varying Ejection Fraction

Ankeet Bhatt

Watch time: 4m 45s
HFA 23: NUDGE-FLU: Increasing Influenza Vaccination in HF Patients

Niklas Dyrby Johansen

Watch time: 4m 53s
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Marianna Fontana

Watch time: 3m 11s
HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in symptomatic nHCM

Ahmad Masri

Watch time: 6m 54s
HFA 23: DAPA-RESIST: Dapagliflozin Vs Metolazone in Diuretic-Resistant HF

Ross Campbell

Watch time: 3m 56s
HFA 23 Late-Breaker Discussion: Hospital to Home in Heart Failure

Harriette Van Spall, Tariq Ahmad, Jozine ter Maaten, et al

Watch time: 26m 30s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s